Medicine composition for treating esophagitis
A composition and technology for esophagitis, applied in the field of western medicine, can solve the problems of interpharyngeal mucosa trauma, ulcers, esophageal stenosis, etc., and achieve non-toxic and side effects, significant curative effect, and quick effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0017] In an embodiment of the present invention, a pharmaceutical composition for treating esophagitis, the active ingredient is composed of the following components in parts by mass: 12 parts of anisodamine, 0.5 part of tamoxifen, and 59 parts of allicin.
Embodiment 2
[0019] In an embodiment of the present invention, a pharmaceutical composition for treating esophagitis, the active ingredient is composed of the following components in parts by mass: 15 parts of anisodamine, 0.8 part of tamoxifen, and 54 parts of allicin.
Embodiment 3
[0021] In an embodiment of the present invention, a pharmaceutical composition for treating esophagitis, the active ingredient is composed of the following components in parts by mass: 13 parts of anisodamine, 0.6 part of tamoxifen, and 58 parts of allicin.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com